Resolving and mitigating medicine shortages in the EU

10 February 2020

Drug shortages can greatly impact patients and the pharmaceutical industry. […]

Biosimilar Uptake in Europe: Big Challenges; Bigger Rewards

16 January 2020

Since the first treatment was approved in 2006, Europe has […]

Biosimilars ‒ Policy failings that deny savings to countries that need it most

21 November 2019

Future and Challenges of the Pharmaceutical Industry

14 November 2019

Interview: Adrian van den Hoven, Director General of Medicines for Europe

8 January 2019

Over the last ten years, generic medicines have increased access […]

SPC manufacturing waiver is good news for Europe

19 September 2018

An SPC manufacturing waiver should be extremely beneficial for Europe […]

Analysis of the proposal for a regulation of a manufacturing exception related to the SPC and aimed to make the European industry competitive

13 September 2018

Andriukaitis: SPC manufacturing waiver does not damage pharma innovation

12 June 2018

Access to Biosimilars in EU Expected to Continue to Outpace US and Canada

26 April 2018

Stakeholders To Gather In London To Plan Biosimilar Market’s Future

17 April 2018